ReShape Lifesciences Inc. ( RSLS) - Key Metrics
Stock symbol RSLS is outdated, potentially delisted? Maybe it is available on other exchange?
RSLS Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2024Q3 | $4.50 | -$3.11 | -$0.61 | -$0.61 |
| 2024Q2 | $4.52 | -$3.67 | -$3.12 | -$3.12 |
| 2024Q1 | $4.81 | -$5.42 | -$5.12 | -$5.12 |
| 2023Q4 | $4.90 | -$4.20 | -$6.08 | -$6.08 |
| 2023Q3 | $36.20 | -$59.37 | -$46.70 | -$46.70 |
RSLS Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2024Q3 | ? | -0.45 |
| 2024Q2 | ? | -0.79 |
| 2024Q1 | ? | -0.43 |
| 2023Q4 | ? | -0.86 |
| 2023Q3 | ? | -0.08 |
RSLS
Price: $3.92
52 week price:
Earnings Per Share: 264.12 USD
P/E Ratio: 0.01
Exchange: NCM
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 32400
Market Capitalization: 5.9 million